KHRN.H — Khiron Life Sciences Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Khiron Life Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2017 May 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.045 | -19.8 | -36.4 | -23.9 | -33.6 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | — | 3.29 | 8.52 | 0.189 | 13.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.023 | 1.33 | -3.18 | -1.94 | -1.86 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.021 | -14.8 | -30.1 | -24.5 | -20.4 |
Capital Expenditures | — | -3.83 | -6.09 | -2.69 | -1.74 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -5.39 | -25.9 | 27.6 | -0.342 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -9.22 | -32 | 24.9 | -2.09 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.005 | 37.6 | 57 | 12.2 | 10.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.016 | 13.2 | -5.67 | 12.3 | -12.7 |